Details of the Drug Formulaction

General Information of Drug Formulation (ID: F02699)

• Formulation Name: Bosutinib 100 mg tablet
• Company: U.S. Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Bosutinib	(DMTI8YE)	Blast phase chronic myelogenous leukemia, BCR-ABL1 positive		Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Carmellose sodium	(E00625)	Not Available	Disintegrant
Ferric hydroxide oxide yellow	(E00539)	23320441	Colorant
Magnesium stearate	(E00208)	11177	lubricant
Poloxamer 188	(E00645)	Not Available	Emulsifying agent; Solubilizing agent; Surfactant
Polyethylene glycol 3350	(E00652)	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Polyvinyl alcohol	(E00666)	Not Available	Coating agent; Emulsion stabilizing agent; Film/Membrane-forming agent
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent